Position in BEAM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,843,739
-$1,714,400 QoQ
Shares Held
53,722
-58.1% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#88
of 274 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BEAM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. BEAM ranks #54 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in BEAM
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,843,739 | 53,722 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $3,558,139 | 128,360 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,186,104 | 296,090 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,892,942 | 228,862 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $385,168 | 15,531 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $245,416 | 10,017 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $715,013 | 30,517 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,608,981 | 48,698 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $694,246 | 25,505 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,853,581 | 77,072 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,391,684 | 74,904 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,043,070 | 34,065 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $797,844 | 20,400 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $739,896 | 15,531 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,241,309 | 57,900 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $976,999 | 12,260 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $548,859 | 6,308 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $257,420 | 2,000 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||